The world is currently experiencing a huge challenge which has affected all the industries and markets. Few markets have experienced a high growth in their demand while others have faced a downfall. The extent of growth or drop in the market statistics of different industries by COVID 19 plays an important role in how the future of businesses will shape up in the near future. We at Value Market Research provide you with an impact analysis of COVID 19 on this market with its latest update in the purchased version of the report.
Global Fatty Liver Treatment Market Report By Drugs (Thiazolidinedione, Vitamin E, Metformin, Statins, Polyunsturated Fatty Acids, Angiotensin Receptor Blockers, Pentoxifyline), By End-user Type (Hospital, Clinics) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2021-2028
ID:VMR11220580
March 2023
Report Formats: Electronic (PDF), MS EXCEL
The global demand for Fatty Liver Treatment Market is presumed to reach the market size of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period 2022 - 2028.
Fatty liver disease is a condition where fat is accumulated in the liver cells. Fatty liver disease commonly occurs due to excessive alcohol consumption, but it can also occur in people who don't drink heavily and is known as nonalcoholic fatty liver disease (NAFLD). Fatty liver disease can progress to more severe forms of liver disease, including cirrhosis and liver failure. The treatment for fatty liver disease depends on the underlying cause and severity of the disease.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of fatty liver treatment. The growth and trends of fatty liver treatment industry provide a holistic approach to this study.
By Drugs
By End-User Type
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the fatty liver treatment market include Cardax Inc, Daewoong Co. Ltd, Hoffmann-La Roche Ltd, Glenmark, GW Pharmaceuticals, Limerick BioPharma Inc, Merck & Co. Inc, Novartis AG, Orchid Chemicals & Pharmaceuticals Ltd, AstraZeneca. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
Fatty liver disease is a condition where fat is accumulated in the liver cells. Fatty liver disease commonly occurs due to excessive alcohol consumption, but it can also occur in people who don't drink heavily and is known as nonalcoholic fatty liver disease (NAFLD). Fatty liver disease can progress to more severe forms of liver disease, including cirrhosis and liver failure. The treatment for fatty liver disease depends on the underlying cause and severity of the disease.
Market Dynamics
Fatty liver disease is becoming more prevalent worldwide, driven by factors such as obesity, sedentary lifestyles, and unhealthy diets. This is leading to a growing demand for effective treatment options for the disease. Fatty liver disease was once considered a relatively benign condition, but research has shown that it can progress to more severe forms of liver disease. This is leading to greater awareness of the disease among patients and healthcare professionals, driving demand for better treatment options. Currently, there are few effective treatments for fatty liver disease, particularly for the more severe forms of the disease. This is driving demand for new treatment options that can help improve liver function and reduce the risk of complications. There is ongoing research into new treatment options for fatty liver disease, including the development of new medications, devices, and surgical procedures. These advancements are driving innovation in the market and increasing the likelihood of new, effective treatments becoming available in the future.The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of fatty liver treatment. The growth and trends of fatty liver treatment industry provide a holistic approach to this study.
Market Segmentation
This section of the fatty liver treatment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.By Drugs
- Thiazolidinedione
- Vitamin E
- Metformin
- Statins
- Polyunsturated Fatty Acids
- Angiotensin Receptor Blockers
- Pentoxifyline
By End-User Type
- Hospital
- Clinics
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Fatty Liver Treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.Global Fatty Liver Treatment Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the fatty liver treatment market include Cardax Inc, Daewoong Co. Ltd, Hoffmann-La Roche Ltd, Glenmark, GW Pharmaceuticals, Limerick BioPharma Inc, Merck & Co. Inc, Novartis AG, Orchid Chemicals & Pharmaceuticals Ltd, AstraZeneca. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
1 . PREFACE
1.1. Report Description
1.1.1. Objective
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
2.1. Highlights of Market
2.2. Global Market Snapshot
3 . FATTY LIVER TREATMENT – INDUSTRY ANALYSIS
3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter’s Five Force Analysis
3.7. Market Attractiveness Analysis
3.7.1 Market Attractiveness Analysis By Drugs
3.7.2 Market Attractiveness Analysis By End-user Type
3.7.3 Market Attractiveness Analysis By Region
4 . VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Raw Material Manufactures List
4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
5.1. Impact Analysis of Covid-19 Outbreak
5.1.1. Direct Impact on Production
5.1.2. Supply Chain and Market Disruption
5.1.3. Financial Impact on Firms and Financial Markets
5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
5.3. Market: Pre V/S Post COVID-19
5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
5.5. COVID-19: Micro and Macro Factor Analysis
6 . GLOBAL FATTY LIVER TREATMENT MARKET ANALYSIS BY DRUGS
6.1 Overview by Drugs
6.2 Historical and Forecast Data
6.3 Analysis by Drugs
6.4 Thiazolidinedione Historic and Forecast Sales by Regions
6.5 Vitamin E Historic and Forecast Sales by Regions
6.6 Metformin Historic and Forecast Sales by Regions
6.7 Statins Historic and Forecast Sales by Regions
6.8 Polyunsturated Fatty Acids Historic and Forecast Sales by Regions
6.9 Angiotensin receptor Blockers Historic and Forecast Sales by Regions
6.10. Pentoxifyline Historic and Forecast Sales by Regions
7 . GLOBAL FATTY LIVER TREATMENT MARKET ANALYSIS BY END-USER TYPE
7.1 Overview by End-user Type
7.2 Historical and Forecast Data
7.3 Analysis by End-user Type
7.4 Hospital Historic and Forecast Sales by Regions
7.5 Clinics Historic and Forecast Sales by Regions
8 . GLOBAL FATTY LIVER TREATMENT MARKET ANALYSIS BY GEOGRAPHY
8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
8.3.1. Overview, Historic and Forecast Sales Analysis
8.3.2. North America By Segment Sales Analysis
8.3.3. North America By Country Sales Analysis
8.3.4. United State Sales Analysis
8.3.5. Canada Sales Analysis
8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
8.4.1. Overview, Historic and Forecast Sales Analysis
8.4.2. Europe by Segment Sales Analysis
8.4.3. Europe by Country Sales Analysis
8.4.4. United Kingdom Sales Analysis
8.4.5. France Sales Analysis
8.4.6. Germany Sales Analysis
8.4.7. Italy Sales Analysis
8.4.8. Russia Sales Analysis
8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
8.5.1. Overview, Historic and Forecast Sales Analysis
8.5.2. Asia Pacific by Segment Sales Analysis
8.5.3. Asia Pacific by Country Sales Analysis
8.5.4. China Sales Analysis
8.5.5. India Sales Analysis
8.5.6. Japan Sales Analysis
8.5.7. South Korea Sales Analysis
8.5.8. Australia Sales Analysis
8.5.9. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
8.6.1. Overview, Historic and Forecast Sales Analysis
8.6.2. Latin America by Segment Sales Analysis
8.6.3. Latin America by Country Sales Analysis
8.6.4. Brazil Sales Analysis
8.6.5. Argentina Sales Analysis
8.6.6. Peru Sales Analysis
8.6.7. Chile Sales Analysis
8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
8.7.1. Overview, Historic and Forecast Sales Analysis
8.7.2. Middle East & Africa by Segment Sales Analysis
8.7.3. Middle East & Africa by Country Sales Analysis
8.7.4. Saudi Arabia Sales Analysis
8.7.5. UAE Sales Analysis
8.7.6. Israel Sales Analysis
8.7.7. South Africa Sales Analysis
8.7.8. Rest Of Middle East And Africa Sales Analysis
9 . COMPETITIVE LANDSCAPE OF THE FATTY LIVER TREATMENT COMPANIES
9.1. Fatty Liver Treatment Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments
10 . COMPANY PROFILES OF FATTY LIVER TREATMENT INDUSTRY
10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Cardax Inc
10.3.1. Company Overview
10.3.2. Company Revenue
10.3.3. Products
10.3.4. Recent Developments
10.4. Daewoong Co. Ltd
10.4.1. Company Overview
10.4.2. Company Revenue
10.4.3. Products
10.4.4. Recent Developments
10.5. Hoffmann-La Roche Ltd
10.5.1. Company Overview
10.5.2. Company Revenue
10.5.3. Products
10.5.4. Recent Developments
10.6. Glenmark
10.6.1. Company Overview
10.6.2. Company Revenue
10.6.3. Products
10.6.4. Recent Developments
10.7. GW Pharmaceuticals
10.7.1. Company Overview
10.7.2. Company Revenue
10.7.3. Products
10.7.4. Recent Developments
10.8. Limerick BioPharma Inc
10.8.1. Company Overview
10.8.2. Company Revenue
10.8.3. Products
10.8.4. Recent Developments
10.9. Merck & Co. Inc
10.9.1. Company Overview
10.9.2. Company Revenue
10.9.3. Products
10.9.4. Recent Developments
10.10. Novartis AG
10.10.1. Company Overview
10.10.2. Company Revenue
10.10.3. Products
10.10.4. Recent Developments
10.11. Orchid Chemicals & Pharmaceuticals Ltd
10.11.1. Company Overview
10.11.2. Company Revenue
10.11.3. Products
10.11.4. Recent Developments
10.12. AstraZeneca.
10.12.1. Company Overview
10.12.2. Company Revenue
10.12.3. Products
10.12.4. Recent Developments
*Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
LIST OF TABLES
- Market Snapshot
- Drivers : Impact Analysis
- Restraints : Impact Analysis
- List of Raw Material
- List of Raw Material Manufactures
- List of Potential Buyers
- COVID-19 Impact Analysis by Production, Import, Export and Demand
- Pre V/S Post COVID-19
- Estimated Impact Of The Coronavirus (Covid-19) Epidemic
- COVID-19: Micro and Macro Factor Analysis
- Analysis by Drugs (USD MN)
- Thiazolidinedione Market Sales by Geography (USD MN)
- Vitamin E Market Sales by Geography (USD MN)
- Metformin Market Sales by Geography (USD MN)
- Statins Market Sales by Geography (USD MN)
- Polyunsturated Fatty Acids Market Sales by Geography (USD MN)
- Angiotensin receptor Blockers Market Sales by Geography (USD MN)
- Pentoxifyline Market Sales by Geography (USD MN)
- Analysis Market by End-user Type (USD MN)
- Hospital Market Sales by Geography (USD MN)
- Clinics Market Sales by Geography (USD MN)
- Global Fatty Liver Treatment Market Sales by Geography (USD MN)
- North America Market Analysis (USD MN)
- United State Market Analysis (USD MN)
- Canada Market Analysis (USD MN)
- Mexico Market Analysis (USD MN)
- Europe Market Analysis (USD MN)
- Europe Market Estimate by Country (USD MN)
- United Kingdom Market Analysis (USD MN)
- France Market Analysis (USD MN)
- Germany Market Analysis (USD MN)
- Italy Market Analysis (USD MN)
- Russia Market Analysis (USD MN)
- Spain Market Analysis (USD MN)
- Rest of Europe Market Analysis (USD MN)
- Asia Pacific Market Analysis (USD MN)
- China Market Analysis (USD MN)
- Japan Market Analysis (USD MN)
- India Market Analysis (USD MN)
- South Korea Market Analysis (USD MN)
- Australia Market Analysis (USD MN)
- Rest of Asia Pacific Market Analysis (USD MN)
- Latin America Market Analysis (USD MN)
- Brazil Market Analysis (USD MN)
- Argentina Market Analysis (USD MN)
- Peru Market Analysis (USD MN)
- Chile Market Analysis (USD MN)
- Rest of Latin America Market Analysis (USD MN)
- Middle East & Africa Market Analysis (USD MN)
- Saudi Arabia Market Analysis (USD MN)
- UAE Market Analysis (USD MN)
- Israel Market Analysis (USD MN)
- South Africa Market Analysis (USD MN)
- Rest of Middle East and Africa Market Analysis (USD MN)
- Partnership/Collaboration/Agreement
- Mergers And Acquisition
LIST OF FIGURES
- Research Scope of Fatty Liver Treatment Report
- Market Research Process
- Market Research Methodology
- Global Fatty Liver Treatment Market Size, by Region (USD MN)
- Porters Five Forces Analysis
- Market Attractiveness Analysis by Drugs
- Market Attractiveness Analysis by End-user Type
- Market Attractiveness Analysis by Region
- Value Chain Analysis
- Global Market Analysis by Drugs (USD MN)
- Thiazolidinedione Market Sales by Geography (USD MN)
- Vitamin E Market Sales by Geography (USD MN)
- Metformin Market Sales by Geography (USD MN)
- Statins Market Sales by Geography (USD MN)
- Polyunsturated Fatty Acids Market Sales by Geography (USD MN)
- Angiotensin receptor Blockers Market Sales by Geography (USD MN)
- Pentoxifyline Market Sales by Geography (USD MN)
- Global Market Analysis by End-user Type (USD MN)
- Hospital Market Sales by Geography (USD MN)
- Clinics Market Sales by Geography (USD MN)
- Global Market by Revenue
- North America Market by Revenue
- Europe Market by Revenue
- Asia Pacific Market by Revenue
- Latin America Market by Revenue
- Middle East & Africa Market by Revenue
- Recent Development in Industry
- Top Companies Market Share Analysis
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
Related Categories
Healthcare
Buy Chapters or Sections
Avail customized purchase options to meet your exact research needs:
- Buy sections of this report
- Buy country level reports
- Request for historical data
- Request discounts available for Start-Ups & Universities
Objectives of Study
- Define and measure the global market
- Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
- Analyze and identify major market trends along with the factors driving or inhibiting the market growth
- Study the company profiles of the major market players with their market share
- Analyze competitive developments